All patients without local follow-up imaging (n = 5 patients with n = 6 lesions) had prostate cancer and received regular controls of prostate-specific antigen (PSA), with a median time from SIB–SBRT to last PSA control of 13 months (R 1–36). This evidence concerns the gene KLK3 and prostate carcinoma.